Kristel Vandormael
MSD (Belgium) · 31 works · 3,581 citations · h-index 16
Top works
- Alendronate for the Treatment of Osteoporosis in Men
- Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement Therapy
- Comparison of Rizatriptan 10 mg vs. Naratriptan 2.5 mg in Migraine
- Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US
- Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
- A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients
- Effect of Rizatriptan and Other Triptans on the Nausea Symptom of Migraine: A Post Hoc Analysis
- Effect of montelukast for treatment of asthma in cigarette smokers
- Weekly Oral Alendronic Acid in Male Osteoporosis
- Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison
- Efficacy of the selective extrasynaptic GABAA agonist, gaboxadol, in a model of transient insomnia: A randomized, controlled clinical trial
- A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC
- Effect of Gaboxadol on Patient-reported Measures of Sleep and Waking Function in Patients with Primary Insomnia: Results from Two Randomized, Controlled, 3-month Studies
- Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial
- Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?
- A Phase I Randomized, Placebo-Controlled, Dose-Exploration Study of Single-Dose Inhaled Montelukast in Patients with Chronic Asthma
- Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up
- The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma